Rivalry Announces Closing of Private Placement and Debt

TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry“) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for digital-first players, is pleased to announce that it has closed the third tranche of its non-brokered private placement (the “Private Placement“) previously announced on September 29, 2025. The Company issued … Read more

Enzon and Viskase Announce Amendment to Merger Agreement

CRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (“Viskase”) today announced that they have entered into an amendment (the “Amendment”) to the previously disclosed Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which … Read more

Jurrien Timber Has Been Arsenal’s Best Player So Far This Season

LONDON, ENGLAND – OCTOBER 21: Jurrien Timber of Arsenal during the UEFA Champions League 2025/26 League Phase MD3 match between Arsenal FC and Atletico de Madrid at Arsenal Stadium on October 21, 2025 in London, England. (Photo by James Gill – Danehouse/Getty Images) Getty Images There is a growing sense that this might be Arsenal’s … Read more

Ultragenyx Reports Inducement Grant Under Nasdaq Listing

NOVATO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 20,317 restricted stock units of the company’s common stock to 17 newly hired non-executive officers of the company. The awards … Read more

Manhattan Bridge Capital, Inc. Reports Third Quarter 2025

GREAT NECK, N.Y., Oct. 24, 2025 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its net income for the three months ended September 30, 2025 was approximately $1,202,000, or $0.11 per basic and diluted share (based on approximately 11.4 million weighted-average outstanding common shares), as compared to approximately $1,399,000, or … Read more

Talisker Closes First Tranche of Bought Deal Private

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK) is pleased to announce the closing of the first tranche (the “First Tranche”) of its previously announced “bought deal” private placement (the “Offering”) … Read more